When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
RVXCF - Resverlogix's apadetalone nabs accelerated review in U.S.; shares up 15%
Resverlogix Corp
The FDA has granted Breakthrough Therapy status to Resverlogix's (OTCPK:RVXCF+14.8%) apabetalone (RVX-208), combined with standard-of-care treatment, including high-intensity statins, for the secondary prevention of major adverse cardiac events in patients with type 2 diabetes and recent acute coronary syndrome.
More news on: Resverlogix Corp., Healthcare stocks news, Stocks on the move,